Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:TFIIH
|
| gptkbp:affects |
gptkb:skincare_product
|
| gptkbp:associated_with |
pigmented lesions
cataracts photosensitivity XP genes premature aging of the skin xerosis |
| gptkbp:caused_by |
defects in DNA repair mechanisms
|
| gptkbp:descendant |
autosomal recessive
|
| gptkbp:first_described_by |
in 1968
|
| https://www.w3.org/2000/01/rdf-schema#label |
xeroderma pigmentosum
|
| gptkbp:is_popular_in |
1 in 250,000 people
|
| gptkbp:public_awareness |
increased public awareness needed
|
| gptkbp:research |
ongoing studies on gene therapy
investigations into new treatments studies on skin cancer prevention understanding of DNA repair mechanisms |
| gptkbp:risk_factor |
family history
UV exposure |
| gptkbp:social_responsibility |
genetic testing
clinical evaluation |
| gptkbp:supports |
advocacy for research funding
educational resources for families patient support groups available |
| gptkbp:symptoms |
gptkb:healthcare_organization
neurological issues eye problems extreme sensitivity to ultraviolet light freckling of the skin |
| gptkbp:treatment |
psychological support
sun protection topical retinoids chemotherapy for skin cancers immunotherapy for skin cancers radiation therapy for skin cancers regular skin examinations surgical removal of skin cancers vitamin D supplementation |
| gptkbp:type |
gptkb:XP-A
XP-B XP-C XP-D XP-E XP-F XP-G XP-H |